QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dmd.106.009696v1 34/7/1128    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Edwards, D. Articles by Ahlström, H. Search for Related Content PubMed PubMed Citation Articles by Edwards, D. Articles by Ahlström, H.

THE IN VIVO AND IN VITRO METABOLIC PROFILE OF ^99MTC-NC100668, A NEW TRACER FOR IMAGING VENOUS THROMBOEMBOLISM: IDENTIFICATION AND BIODISTRIBUTION OF THE PRINCIPAL RADIOLABELED METABOLITE

Research and Development, GE Healthcare Bio-Sciences, Little Chalfont, Buckinghamshire, United Kingdom (D.E., M.B., R.L., G.F., D.J.B., V.G., C.C., A.O.); and Institution of Oncology, Radiology, and Clinical Immunology, Section of Radiology, Uppsala University Hospital, Uppsala, Sweden (D.E., H.A.)

^99mTc-NC100668 [Acetyl-Asn-Gln-Glu-Gln-Val-Ser-Pro-Tyr(3-iodo)-Thr-Leu-Leu-Lys-Gly-NC100194] is a radiopharmaceutical imaging agent being developed to aid the diagnosis of thromboembolism. The stability profile of ^99mTc-NC100668 was investigated by high-performance liquid chromatography (HPLC) after in vitro exposure to blood and plasma obtained from rat and human, as well as to urine and bile obtained from rat. The metabolic profile of ^99mTc-NC100668 exposed to human and rat hepatic S9 (a liver homogenate-rich cytochrome P450) was also studied. The profile of ^99mTc-labeled species in plasma, urine, and bile was investigated following i.v. administration of ^99mTc-NC100668 to rat. The major species observed in vitro and in vivo consisted of the ^99mTc-chelator (NC100194) [N,N-Bis(N-(1,1-dimethyl-2-(hydroxylimino-)propyl)aminoethyl)aminoethylamine] attached to the C-terminal amino acid residue and referred to as ^99mTc-complex of Gly-NC100194. The identity of the major metabolite was confirmed by cochromatography with an authentic standard and the genuine metabolite using a second HPLC method. The minor metabolites were sodium pertechnetate (^99mTc) and ^99mTc-NC100194. In addition, a small number of other species were transiently observed in vitro; they were not investigated further. The biodistribution of the major metabolite was studied in male Wistar rats. The affinity of the major metabolite toward plasma clot was established using a plasma clot-forming assay. A minor uptake of ^99mTc-complex of Gly-NC100194 in the plasma clot and a rapid removal from the body were noted. In conclusion, the metabolites of ^99mTc-NC100668 are not anticipated to have a negative impact on the ability of the test substance to image blood clots.

This article has been cited by other articles:

				K. G. Toft, J. A. Johnson, I. Oulie, and T. Skotland NC100668, a New Tracer Tested for Imaging of Venous Thromboembolism: Pharmacokinetics and Metabolism in Humans Drug Metab. Dispos., November 1, 2007; 35(11): 1979 - 1984. [Abstract] [Full Text] [PDF]